Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20361916 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: agomelatine;   Drug: placebo

Indicates status has not been verified in more than two years